Search for: "David Merrell" Results 1 - 20 of 91
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2024, 4:08 pm by admin
Merrell Dow Pharms., Inc., 509 U.S. 579, 593-594 (1993). [2] Id. at 594 (internal citations omitted) (emphasis added). [3] Id [read post]
29 Mar 2024, 8:22 am by admin
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993). [6] General Electric Co. v. [read post]
27 Feb 2024, 12:07 pm by admin
Antic proposals abound in the legal analysis of expert witness opinion evidence. [read post]
19 Nov 2023, 2:31 pm by admin
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993) (No. 92-102) (proposing that publication in a peer-reviewed journal be the primary criterion for admitting scientifc evidence in the courtroom). [read post]
12 Jun 2023, 1:09 pm by admin
In scientific publishing, when scientists make a mistake, they publish an erratum or a corrigendum. [read post]
16 Mar 2023, 4:30 am by Lawrence Solum
Merrell Dow Pharmaceuticals, Inc., (1993), on the standards for expert testimony, with 24 departing states, United States v. [read post]
10 Feb 2023, 4:44 am by admin
In the third edition’s chapter on statistics, David Kaye and co-author, the late David A. [read post]
17 Jun 2022, 2:09 pm by admin
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
3 May 2022, 10:28 am by Eugene Volokh
Merrell Dow Pharmaceuticals, Inc. (1993), the Supreme Court explained that Rule 702 imposes an obligation on a trial court to act as gatekeeper, to ensure that any and all scientific [or technical or otherwise specialized] testimony or evidence admitted is not only relevant, but reliable. [read post]
12 Dec 2021, 2:22 pm by admin
In assessing an association for causality, the starting point is “an association between two variables, perfectly clear-cut and beyond what we would care to attribute to the play of chance. [read post]
19 Dec 2020, 1:57 pm by Schachtman
Merrell Dow Pharms., Inc., 33 Phila. [read post]
19 Dec 2020, 1:57 pm by admin
Merrell Dow Pharms., Inc., 33 Phila. [read post]
8 May 2020, 3:47 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [2]  Frye v. [read post]
4 Oct 2019, 4:38 pm by Unknown
Nor do I mean the capacity—or inclination—of courts to produce social change against the tide of dominant political forces, which I shall call judicial independence.Extensions, Applications, and Friendly AmendmentsIn illuminating and complementary posts, David Marcus and Aaron-Andrew Bruhl draw attention to judicial capacity issues in the lower federal courts that I do not discuss at any length in my book. [read post]
13 Sep 2019, 6:00 am by Guest Blogger
For the symposium on Andrew Coan, Rationing the Constitution: How Judicial Capacity Shapes Supreme Court Decision-Making (Harvard University Press 2019).Frederick SchauerAndrew Coan’s important book[i]on the limits of the Supreme Court’s decision-making capacity is built on three foundational points, all of which are correct. [read post]
22 Jan 2019, 2:30 am by Tinker Ready
Ryan Gabrielson ProPublica Originally published at ProPublica January 17 , 2019 At the FBI Laboratory in Quantico, Virginia, a team of about a half-dozen technicians analyzes pictures down to their pixels, trying to determine if the faces, hands, clothes or cars of suspects match images collected by investigators from cameras at crime scenes. [read post]
28 Dec 2018, 2:22 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), appealed a Ninth Circuit ruling that the Frye rule survived, and was incorporated into, the enactment of a statutory evidentiary rule, Rule 702. [read post]